# Traditional Chinese Medicine Formulae QY305 Reducing Cutaneous Adverse Reaction and Diarrhea by its Nanostructure

**Authors:** Ya‐Li Zhang, Ya‐Lei Wang, Ke Yan, Haiyan Li, Xinyu Zhang, Julien Milon Essola, Chengcheng Ding, Kexin Chang, Guangchao Qing, Fuxue Zhang, Yan Tan, Tiantian Peng, Xu Wang, Miao Jiang, Xing‐Jie Liang, Qian Hua

PMC · DOI: 10.1002/advs.202306140 · Advanced Science · 2023-12-03

## TL;DR

A traditional Chinese medicine formula called QY305 reduces skin and gut side effects caused by certain drugs, with its nanostructure playing a key role.

## Contribution

The study identifies a nanostructure within QY305 as the key pharmacodynamic component responsible for its therapeutic effects.

## Key findings

- QY305 reduces cutaneous adverse reactions and diarrhea in both human and animal models.
- The nanostructure N-QY305 is more potent than the full QY305 formula in reducing adverse effects.
- The nanostructure N-QY305 is proposed as the 'King' component of the TCM formula.

## Abstract

Traditional Chinese medicine (TCM) is widely used in clinical practice, including skin and gastrointestinal diseases. Here, a potential TCM QY305 (T‐QY305) is reported that can modulate the recruitment of neutrophil in skin and colon tissue thus reducing cutaneous adverse reaction and diarrhea induced by epidermal growth factor receptor inhibitors (EGFRIs). On another hand, the T‐QY305 formula, through regulating neutrophil recruitment features would highlight the presence of N‐QY305, a subunit nanostructure contained in T‐QY305, and confirm its role as potentially being the biomaterial conferring to T‐QY305 its pharmacodynamic features. Here, the clinical records of two patients are analyzed expressing cutaneous adverse reaction and demonstrate positive effect of T‐QY305 on the simultaneous inhibition of both cutaneous adverse reaction and diarrhea in animal models. The satisfying results obtained from T‐QY305, lead to further process to the isolation of N‐QY305 from T‐QY305, in order to demonstrate that the potency of T‐QY305 originates from the nanostructure N‐QY305. Compared to T‐QY305, N‐QY305 exhibits higher potency upon reducing adverse reactions. The data represent a promising candidate for reducing cutaneous adverse reaction and diarrhea, meanwhile proposing a new strategy to highlight the presence of nanostructures being the “King” of Chinese medicine formula as the pharmacodynamic basis.

Chinese medicine formula T‐QY305 can reduce cutaneous adverse reaction and diarrhea induced by EGFRIs both in human and animals, which corresponds to “Jun”‐“Chen”‐“Zuo”‐“Shi” TCM theory. Meanwhile a new strategy is proposed to highlight the presence of nanostructure N‐QY305 being the “King” of Chinese medicine formula as the pharmacodynamic basis.

## Linked entities

- **Diseases:** diarrhea (MONDO:0001673)

## Full-text entities

- **Genes:** Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Cd68 (Cd68 molecule) [NCBI Gene 287435], Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, Mpo (myeloperoxidase) [NCBI Gene 303413], Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}
- **Diseases:** Carrying Tumor (MESH:D009369), non-small cell lung cancer (MESH:D002289), TCM (MESH:C562377), rash (MESH:D005076), EGFRIs (MESH:C565529), pruritus (MESH:D011537), constipation (MESH:D003248), loss of body weight (MESH:D001835), breast cancer (MESH:D001943), toxicities (MESH:D064420), Cutaneous Adverse Reaction (MESH:D013262), paronychia (MESH:D010304), inflammatory (MESH:D007249), colorectal carcinoma (MESH:D015179), Diarrhea (MESH:D003967), skin and gastrointestinal diseases (MESH:D005767)
- **Chemicals:** Minocin (MESH:D008911), Chinese herbal (-), isoflurane (MESH:D007530), N (MESH:D009584), PBS (MESH:D007854), H&amp;E (MESH:D006371), DAB (MESH:C000469), T (MESH:D014316), H2O (MESH:D014867), L (MESH:D007930), chlorogenic acid (MESH:D002726), sodium citrate (MESH:D000077559), polyester (MESH:D011091), DiD (MESH:D017878), ethanol (MESH:D000431), hematoxylin (MESH:D006416), Gefitinib (MESH:D000077156), FITC (MESH:D016650), secoxyloganin (MESH:C059515), DAPI (MESH:C007293), Imodium (MESH:D008139), paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606], Astragalus membranaceus (species) [taxon 649199], Angelica sinensis (Chinese angelica, species) [taxon 165353], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Lonicera japonica (Japanese honeysuckle, species) [taxon 105884]
- **Cell lines:** balb/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10837375/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10837375/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC10837375/full.md

---
Source: https://tomesphere.com/paper/PMC10837375